首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   363865篇
  免费   20514篇
  国内免费   1297篇
耳鼻咽喉   4813篇
儿科学   11398篇
妇产科学   8554篇
基础医学   50155篇
口腔科学   12663篇
临床医学   26512篇
内科学   81158篇
皮肤病学   10157篇
神经病学   30273篇
特种医学   10292篇
外国民族医学   73篇
外科学   46243篇
综合类   3560篇
现状与发展   2篇
一般理论   101篇
预防医学   36692篇
眼科学   7262篇
药学   24456篇
  6篇
中国医学   1798篇
肿瘤学   19508篇
  2023年   1981篇
  2022年   4106篇
  2021年   8205篇
  2020年   4941篇
  2019年   7600篇
  2018年   10399篇
  2017年   7280篇
  2016年   7068篇
  2015年   8118篇
  2014年   10981篇
  2013年   14748篇
  2012年   22471篇
  2011年   23289篇
  2010年   12548篇
  2009年   11020篇
  2008年   18372篇
  2007年   19427篇
  2006年   18473篇
  2005年   18666篇
  2004年   17434篇
  2003年   16058篇
  2002年   13893篇
  2001年   10857篇
  2000年   10928篇
  1999年   9438篇
  1998年   3174篇
  1997年   2494篇
  1996年   2351篇
  1995年   1991篇
  1994年   1901篇
  1993年   1713篇
  1992年   5291篇
  1991年   5061篇
  1990年   4653篇
  1989年   4413篇
  1988年   4082篇
  1987年   3823篇
  1986年   3574篇
  1985年   3424篇
  1984年   2520篇
  1983年   2072篇
  1982年   1223篇
  1979年   2100篇
  1978年   1385篇
  1975年   1297篇
  1974年   1524篇
  1973年   1495篇
  1972年   1294篇
  1970年   1274篇
  1969年   1247篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Molnár  B.  Aroca  S.  Dobos  A.  Orbán  K.  Szabó  J.  Windisch  P.  Stähli  A.  Sculean  A. 《Clinical oral investigations》2022,26(12):7135-7142
Clinical Oral Investigations - To evaluate t he long-term outcomes following treatment of RT 1 multiple adjacent gingival recessions (MAGR) using the modified coronally advanced tunnel (MCAT) with...  相似文献   
2.
3.
Journal of Immigrant and Minority Health - COVID-19 has disproportionally affected underrepresented minorities (URM) and low-income immigrants in the United States. The aim of the study is to...  相似文献   
4.
5.
Breast pseudoaneurysms after a core needle biopsy are a rare complication with a low incidence. However, it is important to be aware of the possibility of complications that require treatment.  相似文献   
6.
Introduction: In men, lower urinary tract symptoms (LUTS) are primarily attributed to benign prostatic hyperplasia (BPH). Therapeutic options are targeted to relax prostate smooth muscle and/or reduce prostate enlargement.

Areas covered: This article reviews the major preclinical and clinical data on PDE5 inhibitors with a specific focus on tadalafil. It includes details of the role of the nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) – PDE5 pathway in the LUT organs (bladder and prostate) in addition to the available data on tadalafil in patients with LUTS secondary to BPH with or without erectile dysfunction (ED).

Expert opinion: Preclinical and clinical data have clearly demonstrated that PDE5 inhibitors induce bladder and prostate relaxation, which contributes to the improvement seen in storage symptoms in both animal models of bladder and prostate hypercontractility. Tadalafil is effective both as a monotherapy and add-on therapy in patients with LUTS secondary to BPH. Furthermore, as LUTS-BPH and ED are urological disorders that commonly coexist in aging men, tadalafil is more advantageous than α1-adrenoceptors and should be used as the first option. Tadalafil is a safe and tolerable therapy and unlike α1- adrenoceptors and 5-alpha reductase inhibitors, which can cause sexual dysfunctions, tadalafil improves sexual function.  相似文献   

7.
8.
European Radiology - The strongest adverse prognostic factor in myxoid/round cell liposarcomas (MRC-LPS) is the presence of a round cell component above 5% within the tumor bulk. Its identification...  相似文献   
9.
10.
Introduction: The treatment of classical Hodgkin lymphoma (cHL) in children is a story of success. Nowadays, more than 90% of patients are cured and overall survival is nearly 100% at 5 years. Efforts have been made to avoid related effects of therapies; therefore, children are treated using different chemotherapy schemes in comparison with adults.

Areas covered: This review includes a view of the clinical classification and risk assessment in children suffering from HL. The chemotherapy more commonly employed is revisited. The use of PET/CT to evaluate the disease in order to guide therapy is analyzed. New options of chemotherapy and emerging immunotherapy are also included.

Expert opinion: In order to make the right treatment choice, a proper initial assessment of risk is mandatory. The choice of therapy in these kinds of patients must be done according to the experience of the team, and also, the cost and logistics related to the eligible scheme are very important. If possible, efforts must be made to include PET/CT in guiding therapy and avoiding overtreatment and long-term adverse effects in children. New options in immunotherapy are emerging and must be considered with caution in selected patients.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号